Atlas Trials

The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma

Clinical trial NCT05144087 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05144087
Sponsor
University Hospital Southampton NHS Foundation Trust
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Asthma; Eosinophilic
Start date
2022-05-25
Primary completion
2024-05-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.